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Abstract
RATIONALE—The functional integrity of the dorsal hippocampus (DH) is necessary for drug 
context-induced reinstatement of cocaine seeking. However, the neuropharmacological 
mechanisms of this phenomenon are poorly understood.
OBJECTIVES—Given the known significance of group I metabotropic glutamate receptors 
(group I mGluRs), including the mGluR1 subtype, in drug-induced behaviors, the present study 
was designed to evaluate the contribution of mGluR1s in the DH to drug context-induced 
reinstatement of extinguished cocaine-seeking behavior.
METHODS—Sprague-Dawley rats were trained to lever press for unsignaled cocaine infusions in 
a distinct environmental context (cocaine-paired context) followed by extinction training in a 
distinctly different environmental context (extinction context). Using a counterbalanced within-
subject testing design, rats were re-exposed to the cocaine-paired context or the extinction context 
while cocaine-seeking behavior (non-reinforced active lever pressing) was assessed. Prior to each 
test session, rats received bilateral microinfusions of the highly potent mGluR1-selective 
antagonist JNJ16259685 (0.6, 30 or 120 pg/0.5 µl per hemisphere) or 0.1 % DMSO vehicle into 
the DH or the overlying somatosensory cortex trunk region (SStr, anatomical control).
RESULTS—Intra-DH, but not intra-SStr, JNJ16259685 infusions dose-dependently attenuated 
drug context-induced reinstatement of cocaine seeking, without attenuating instrumental behavior 
in the extinction context, general motor activity, or food-reinforced instrumental behavior in 
control experiments.
CONCLUSIONS—Stimulation of mGluR1s in the DH is necessary for incentive motivational 
and/or memory processes that contribute to drug context-induced cocaine-seeking behavior. These 
findings indicate that the mGluR1 is an interesting target from an addiction treatment perspective.
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Until recently, little attention has been focused on the contribution of the hippocampus to 
addictive behaviors, despite the fact that neural activation of this brain region correlates with 
self-reports of cue-induced craving in drug users (Sell et al. 2000; Wexler et al. 2001; Kilts 
et al. 2001; Schneider et al. 2001; Franklin et al. 2007). Furthermore, the functional integrity 
of the dorsal hippocampus (DH) is necessary for the expression of drug context-induced 
cocaine-seeking behavior in the reinstatement animal model of drug relapse (Fuchs et al. 
2005). However, the neuropharmacological mechanisms of this phenomenon are poorly 
understood.
Group I metabotropic glutamate receptors (mGluRs) have been implicated in a variety of 
drug-induced and context-induced behaviors (McGeeham and Olive 2003; Gravius et al. 
2006), even though it is unclear whether they play a role in drug context-induced cocaine-
seeking behavior per se. Group I mGluRs include the mGluR1 and mGluR5 receptor 
subtypes, which regulate ionotropic glutamate receptor function, multiple forms of neural 
plasticity, and behavioral sensitization to various drugs of abuse, including cocaine 
(Bortolotto et al. 1990; Dravolina 2006; Kotlinska and Bochenski 2007). Specifically, 
stimulation of the mGluR5 subtype is necessary for the acquisition of cocaine-conditioned 
place preference, maintenance of ethanol self-administration, and the expression of cocaine-
seeking and methamphetamine-seeking behaviors in response to an explicit drug-paired 
conditioned stimulus (CS; McGeehan and Olive 2003; Bespalov et al. 2005; Hodge et al. 
2006; Backstrom and Hyytia 2006; 2007; Gass et al. 2008; 2009). Comparatively less is 
known about the contribution of the mGluR1 subtype to drug-induced behaviors due to the 
scarcity of selective mGluR1 antagonists. However, a recent report has demonstrated that 
systemic administration of the mGluR1 antagonist (3-ethyl-2-methyl-quinolin-6-yl)-(4-
methoxy-cyclohexyl)-methanone methanesulfonate (EMQMCM) attenuates CS-induced 
reinstatement of extinguished nicotine-seeking behavior (Dravolina et al. 2007).
The DH is characterized by the highest density of mGluR1s, besides the cerebellum (Masu 
et al. 1991; Shigemoto et al. 1992; Simonyi et al. 2005). Given that the DH is implicated in 
drug context-induced reinstatement of cocaine-seeking behavior (Fuchs et al. 2005) and 
mGluR1s are implicated in some cue-induced behaviors (Dravolina et al. 2007), the present 
study evaluated the hypothesis that stimulation of mGluR1s within the DH is necessary for 
drug context-induced reinstatement of cocaine-seeking behavior. To this end, the dose-
dependent effects of the highly potent mGluR1 subtype-selective antagonist JNJ16259685 
on context-induced reinstatement of cocaine-seeking behavior were assessed in rats. In order 
to discriminate the putative effects of JNJ16259685 on motivation and motor performance, 
we also assessed the effects of JNJ16259685 on non-reinforced instrumental responding in a 
non-cocaine-paired context, on preprandial and postprandial food-reinforced instrumental 
responding, as well as on motor behavior.
MATERIALS AND METHODS
Animals
Male Sprague-Dawley rats (Charles-River, N = 58) weighing 250–275 g at the time of 
surgery, were individually housed under a reverse light/dark cycle. They were maintained on 
20–25 g of rat chow per day, with water available ad libitum. The housing and treatment of 
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the rats followed the guidelines of the “Guide for the Care and Use of Laboratory Rats” 
(Institute of Laboratory Animal Resources, Commission on Life Sciences 1996), and the 
study protocol was approved by the Institutional Animal Care and Use Committee of the 
University of North Carolina at Chapel Hill.
Food training
In order to expedite the acquisition of cocaine self-administration, rats were first trained to 
lever press under a fixed ratio (FR) 1 schedule of food reinforcement (45 mg pellets; Purina, 
Richmond, IN, USA) in standard sound-attenuated operant-conditioning chambers (26 × 27 
× 27 cm high; Coulbourn Instruments, Allentown, PA, USA) during a single 16-h overnight 
food training session. The chambers were equipped with two retractable levers and a food 
pellet dispenser between the levers. During the session, each lever press on one (active) 
lever resulted in delivery of one food pellet only. Lever presses on the second (inactive) 
lever had no programmed consequences. The contextual stimuli used for subsequent 
conditioning were not present during the food training session.
Surgery
Forty-eight hours after food training, rats were anesthetized using ketamine hydrochloride 
and xylazine (66.6 and 1.3 mg/kg, i.p., respectively). Chronic indwelling catheters were 
constructed as described previously (Fuchs et al. 2007; 2008). The end of the catheter was 
inserted into the right jugular vein and was secured to surrounding tissue with suture. The 
catheter ran subcutaneously and exited on the rat’s back, posterior to the shoulder blades. 
Immediately after the catheter surgery, stainless steel guide cannulae (26 G, Plastics One) 
were aimed at the DH (−3.4 mm anterioposterior, +/−3.1 mm mediolateral, −2.15 mm 
dorsoventral, relative to bregma) or the overlying trunk region of the somatosensory cortex 
(SStr: −3.4 mm anterioposterior, +/−3.1 mm mediolateral, −0.65 mm dorsoventral, relative 
to bregma), which served as an anatomical control region. Three stainless steel screws and 
dental acrylic anchored the cannulae. Stylets (Plastics One) and Tygon caps sealed the guide 
cannulae and catheters, respectively, in order to prevent occlusion. Rats were given 5 days 
for post-operative recovery before the start of the experiment.
To extend catheter patency, the catheters were flushed through once daily for 5 days 
following surgery with 0.1 ml of an antibiotic solution of cefazolin (100.0 mg/ml, Schein 
Pharmaceutical, Florham Park, NJ, USA) dissolved in heparinized saline (70 U/ml; Baxter 
Healthcare, Deerfield, IL, USA). Thereafter, catheters were flushed with 0.1 ml of 
heparinized saline (10 U/ml) prior to each self-administration session and with 0.1 ml of the 
cefazolin solution and 0.1 ml of heparinized saline (70 U/ml) after each session. Catheter 
patency was periodically verified by infusing 0.1 ml of propofol (10 mg/ml, intravenous; 
Abbot Labs., North Chicago, IL, USA), an ultra short-acting barbiturate that produces rapid 
loss of muscle tone only when administered intravenously.
Cocaine self-administration training
Cocaine self-administration training was conducted during daily 2-h sessions on a minimum 
of 10 consecutive days during the rats’ dark cycle. The catheters were connected to liquid 
swivels (Instech, Plymouth Meeting, PA, USA) via polyethylene 20 tubing that was encased 
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in steel spring leashes (Plastics One). The swivels were suspended above the operant 
conditioning chamber and were connected to infusion pumps via Tygon tubing (Coulbourn). 
Data collection and reinforcer delivery were controlled using Graphic State Notation 
software version 2.102 (Coulbourn). Rats (N = 48) were trained to press a lever under an FR 
1 schedule of cocaine reinforcement (cocaine hydrochloride; 0.15 mg/0.05 ml per infusion; 
National Institute on Drug Abuse, Research Triangle Park, NC, USA) with a 20-s timeout 
period. After each infusion, responses on this active lever had no programmed consequences 
during the 20-s timeout period. During the sessions, responses on a second, inactive lever 
had no programmed consequences but were recorded.
Self-administration training was conducted in operant-conditioning chambers that contained 
one of two distinctly different sets of multi-modal contextual stimuli as described before 
(Fuchs et al. 2008). Briefly, context 1 contained a continuous red houselight (0.4 fc 
brightness), intermittent pure tone (80 dB, 1 kHz; 2 s on, 2 s off), pine-scented air freshener 
strip, and wire mesh floor (26 cm × 27 cm). Context 2 contained an intermittent white 
stimulus light above the inactive lever (1.2 fc brightness; 2 s on, 2 s off), continuous pure 
tone (75 dB, 2.5 kHz), vanilla-scented air freshener strip, and a slanted ceramic tile wall that 
bisected the bar floor (19 cm × 27 cm). Rats had no exposure to these contextual stimuli 
prior to cocaine self-administration training. These stimuli were presented throughout each 
session independent of responding, as in our previous studies (Fuchs et al. 2005; 2007; 
2008). Assignment of rats to cocaine self-administration training in Context 1 versus 
Context 2 was random. Active lever presses resulted in 2-s activation of the infusion pump 
only. The pump was located outside of the sound attenuated chamber. Daily self-
administration training sessions were continued until a rat reached the acquisition criterion 
(i.e., ≥ 10 infusions self-administered/session on a minimum of 10 training days).
Extinction and reinstatement testing
Rats received daily 2-h extinction training sessions in a context distinctly different from the 
one used for cocaine self-administration training on a minimum of seven consecutive days. 
During the extinction training sessions, responses were recorded on both levers, but had no 
programmed consequences. Rats were adapted to the intracranial infusion procedure prior to 
placement into the operant conditioning chamber on extinction day 4. To this end, injection 
cannulae were inserted bilaterally into the rat’s guide cannulae to a depth 1 mm below the 
tip of the guide cannulae. The injectors were left in place for 4 min, but no fluid was infused. 
Once rats reached the extinction criterion (≤ 25 active lever responses/session on at least 2 
consecutive days), they received two test sessions in the previously cocaine-paired context 
and two test sessions in the extinction context. Five minutes prior to each test session, rats 
received bilateral microinfusions of one dose of the potent and selective mGluR1 antagonist 
JNJ16259685 (0.6, 30, or 120 pg/0.5 µl per hemisphere) or vehicle (0.1 % DMSO, 0.5 µl per 
hemisphere) into the DH or the SStr. Given that the behavioral effects of intracranially 
infused JNJ16259685 have not been previously examined, the antagonist dose range was 
derived from our pilot experiments testing the effects of 0.6–1200 pg/0.5 µl per hemisphere 
doses of JNJ16259685. Infusions were administered at a rate of 0.25 µl/min and injectors 
were left in the cannulae 1 min before and after the infusions. The order of testing in the 
previously cocaine-paired versus extinction contexts and treatment (JNJ16259685, vehicle) 
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were counterbalanced based on mean active lever responding during the last three cocaine 
self-administration training days. Between test sessions, rats received additional extinction 
training sessions until they re-obtained the extinction criterion (described above). During 
each test session, responses on the active and inactive levers were recorded for 1 h, but had 
no programmed consequences.
Locomotor activity testing
To assess possible nonspecific effects of intra-DH JNJ16259685 treatment on general motor 
activity, the effects of intra-DH JNJ16259685 treatment and vehicle on locomotion were 
examined using a partial within-subjects design. Seventy-two hours after the last 
reinstatement test session, rats received bilateral microinfusions of a behaviorally active 
dose of JNJ16259685 (30 or 120 pg/0.5 µl per hemisphere) or vehicle (0.1 % DMSO, 0.5 µl 
per hemisphere) into the DH using the infusion procedures described above. Two tests were 
conducted per rat. Assignment to treatment groups and treatment order were random. 
Horizontal locomotor activity was measured in novel Plexiglas chambers (42 × 20 × 20 cm 
high), as described previously (Fuchs et al. 2007; 2008). The total number of photobeams 
interrupted by a rat moving in the chamber was recorded by a computerized activity system 
(San Diego Instruments, San Diego, CA, USA) during each 1-h test session.
Food-reinforced instrumental behavior
To assess possible nonspecific motor effects of JNJ16259685 on instrumental behavior per 
se, the effects of JNJ16259685 (30 or 120 pg/0.5 µl per hemisphere) and vehicle on food-
reinforced lever pressing behavior were examined. Experimentally naïve rats (N = 18) 
received a single overnight food training session followed by stereotaxic surgery as 
described in the cocaine experiment. Some rats (N = 10, preprandial condition) were food-
deprived overnight prior to the initial food training session and received 20–25 g of rodent 
chow after each training and test session, as in the cocaine experiment. Other rats (N = 8, 
postprandial condition) received free access to additional 100 food pellets (45 mg, Purina) in 
their home cages 1-h before each training and test session. The postprandial condition was 
included in order to elicit lever response rates more similar to those seen during the 
reinstatement test in the cocaine-trained groups. Rats in the preprandial and postprandial 
condition underwent daily 2-h food self-administration training sessions in context 1 or 2, 
modified to include a food pellet dispenser. Assignment of rats to food self-administration 
training in context 1 or 2 was random. Active lever presses resulted in the delivery of a 
single food pellet (45 mg, Purina) under an FR 1 reinforcement schedule with a 20-s timeout 
period. Inactive lever presses were recorded but had no programmed consequences. After 
responding stabilized (i.e., ≤ 20% variability in active lever responding across two 
consecutive sessions), three 1-h test sessions were conducted using a fully counterbalanced 
within-subjects test design. Five minutes before each test session, rats received bilateral 
microinfusions of a behaviorally active dose of JNJ16259685 (30 or 120 pg/0.5 µl per 
hemisphere) or vehicle (0.1 % DMSO, 0.5 µl per hemisphere) into the DH, using the 
infusion procedure described above. During the test sessions, active lever presses continued 
to be reinforced with food pellets under an FR 1 reinforcement schedule with a 20-s timeout 
period. Inactive lever presses were recorded but had no programmed consequences. 
Treatment order was counterbalanced based on mean food-reinforced responding during the 
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last two food self-administration sessions that preceded the first test session. Between the 
test sessions, rats received a minimum of two additional food self-administration training 
sessions to re-establish less than 10% variability in baseline responding.
Histology
After the last experimental session, catheterized rats were fully anesthetized using ketamine 
hydrochloride and xylazine (66.6 and 1.3 mg/kg, i.v., respectively); rats without catheters 
were anesthetized using ketamine hydrochloride and xylazine (199.8 and 3.9 mg/kg, i.p., 
respectively) Rats were then transcardially perfused using 1×phosphate-buffered saline 
(Fisher Scientific) and 10% formaldehyde solution (Sigma). The brains were dissected out 
and stored in 10% formaldehyde solution. The brains were sectioned in the coronal plane at 
a thickness of 75 µm using a vibratome. The sections were mounted onto gelatin-coated 
slides, and stained using cresyl violet (Kodak, Rochester, NY, USA). Cannula placements 
were determined using light microscopy. The most ventral portion of each cannula track was 
mapped onto schematics of appropriate plates from the rat brain atlas (Paxinos and Watson 
1997).
Data analysis
To test for possible pre-existing differences between the treatment groups, cocaine-
reinforced active and inactive lever presses, cocaine infusions, the total number of sessions 
needed to reach the extinction criterion, and extinction responding on the active lever and 
inactive lever were analyzed separately using analyses of variance (ANOVAs) with cannula 
location (DH, SStr) and subsequent treatment (JNJ16259685 doses, vehicle) as between-
subjects factors and time (days) as the within-subjects factor, where appropriate. To test for 
a possible test order effect, non-reinforced active and inactive lever presses on the test days 
were analyzed separately using mixed-factorial ANOVA with testing order (extinction first, 
reinstatement first) as the between-subjects factor and testing context (extinction, cocaine-
paired) as the within-subjects factor. To determine whether the vehicle data can be 
collapsed, non-reinforced active and inactive lever presses on the test days following intra-
DH vehicle administration were analyzed separately using mixed-factorial ANOVA with 
additional treatment (JNJ16259685 doses) as the between-subjects factor and testing context 
(extinction, cocaine-paired) as the within-subjects factor.
To assess the effects of JNJ16259685 on lever responding on the test days, non-reinforced 
active and inactive lever presses were analyzed separately using mixed-factorial ANOVAs 
with treatment (JNJ16259685 doses, vehicle) as the between-subjects factor and testing 
context (extinction, cocaine-paired) as the within-subjects factor. To assess the effects of 
JNJ16259685 on locomotor activity, photobeam breaks were analyzed using a mixed-
factorial ANOVA with treatment (JNJ16259685 doses, vehicle) as the between-subjects 
factor and time (20-min intervals) as the within-subjects factor. Food-reinforced active and 
inactive lever presses were analyzed separately using a repeated-measures one-way 
ANOVA with treatment (JNJ16259685 does, vehicle) as the factor. In all analyses, 
significant ANOVA main and interaction effects were further investigated using Tukey HSD 
tests. Alpha was set at 0.05. Only statistically significant effects are reported below.
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A schematic illustrating cannula placements and photomicrographs showing representative 
cannula tracts are shown in Fig. 1. The target brain regions were defined as the DH and the 
overlying SStr. The most ventral point of the infusion cannula tracks was located within the 
DH (N = 36) or SStr (N = 12) bilaterally in all cocaine-trained rats and within the DH in all 
food-trained rats (N = 18). The resulting sample sizes per group are reported in the figure 
captions for figures 2 and 3. High power microscopy did not reveal any evidence of 
abnormal tissue damage (i.e., extensive cell loss or gliosis) at the infusion site.
Cocaine Self-administration
Both the DH- and SStr-cannulated groups exhibited stable responding on the active lever 
during the last three self-administration training days with a within-subject variability of < 
10% in daily cocaine intake. Collapsed across groups, the mean numbers of active lever 
responses was 53.83 ± 4.87 and the mean daily cocaine intake (± SEM) was approximately 
11.55 ± 1.50 mg/kg per session (23.10 ± 1.50 infusions), based on mean body weight. The 
DH- and SStr-cannulated groups did not differ in active or inactive lever responding during 
the last three days of cocaine self-administration training (all time and cannula location main 
and interaction effects, N.S.). There was also no pre-existing difference between the DH-
cannulated groups that were subsequently assigned to receive JNJ16259685 at a dose of 0.6, 
30, or 120 pg/hemisphere in active or inactive lever responding (all time and treatment main 
and interaction effects, N.S.).
Extinction
Upon the removal of cocaine reinforcement, active and inactive lever responding gradually 
declined in both DH- and SStr-cannulated groups (time main effects, F(6,276) = 7.277–
21.625, p = 0.0001). There was no pre-existing difference between the DH- and SStr-
cannulated groups in active and inactive lever responding during the first seven days of 
extinction training (all cannula location main and interaction effects, N.S.) and in the mean 
number of daily sessions (± SEM; 7.40 ± 0.08) needed to reach the extinction criterion. 
Separate ANOVAs indicated that active and inactive lever responding gradually declined to 
criterion in the three DH-cannulated groups that were assigned to receive different doses of 
JNJ16259685 on subsequent test days (time main effect, F(6,198) = 6.640–28.323, p = 
0.0001). Furthermore, there was no pre-existing difference between these treatment groups 
in active or inactive lever responding during the first seven days of extinction training (all 
treatment main and interaction effects, N.S.) or in the mean number of daily sessions (± 
SEM) needed to reach the extinction criterion (7.30 ± 0.07).
Effects of intra-DH JNJ16259685 treatment on drug context-induced reinstatement of 
cocaine seeking
Exposure to the previously cocaine-paired context reinstated active lever responding in rats 
that received intra-DH or intra-SStr vehicle pretreatment regardless of treatment order and 
treatment history (Fig. 2). Separate 2 × 2 ANOVAs indicated no difference in active or 
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inactive lever responding as a function of test order in the cocaine-paired context versus 
extinction context (all test order main or interaction effects, N.S.). Hence, data were 
collapsed across this variable. There was also no difference in active or inactive lever 
responding following vehicle treatment among the three DH-cannulated treatment groups 
that were assigned to receive different doses of JNJ16259685 on alternate test days (all 
subsequent treatment main or interaction effects, N.S.). Therefore, data were collapsed 
across these groups to form a single vehicle condition.
Intra-DH JNJ16259685 treatment differently altered active lever responding as a function of 
testing context, dose, and infusion site (Fig. 2a). Exposure to the cocaine-paired context 
increased active lever responding following intra-DH vehicle pre-treatment relative to 
responding in the extinction context (context main effect, F(1,68) = 61.758, p = 0.0001). The 
effects of intra-DH JNJ16259685 treatment were dose-dependent in the cocaine-paired 
context (treatment × context interaction effect, F(3,68) = 5.724, p = 0.001 and treatment main 
effect, F(3,68) = 7.541, p = 0.0001). Specifically, the 0.6 pg dose of JNJ16259685 
administered into the DH failed to alter active lever responding in the extinction context or 
in the cocaine-paired context relative to vehicle. In contrast, the 30 or 120 pg doses of 
JNJ16259685 administered into the DH significantly decreased active lever responding in 
the cocaine-paired context (Tukey test, p < 0.05), without altering active lever responding in 
the extinction context, relative to vehicle. Furthermore, following intra-DH administration of 
the 30 or 120 pg doses of JNJ16259685, active lever responding in the cocaine-paired 
context was not significantly different from that in the extinction context. Exposure to the 
cocaine-paired context slightly increased responding on the inactive lever relative to 
responding in the extinction context (context main effect, F(1,68) = 9.766, p = 0.003, Fig. 
2b). However, intra-DH administrations of JNJ16259685 failed to alter inactive lever 
responding in either the cocaine-paired or the extinction context (treatment and context main 
and treatment × context interaction effects, N.S.).
Effects of intra-SStr JNJ16259685 treatment on drug context-induced reinstatement of 
cocaine seeking
Exposure to the previously cocaine-paired context increased active lever responding 
following vehicle pre-treatment administered into the SStr relative to responding in the 
extinction context (context main effect, F(1,11) = 31.482, p = 0.0001, Fig. 2c). However, 
intra-SStr administrations of the 30 pg dose of JNJ16259685, a dose behaviorally effective 
in the DH, failed to alter active lever responding relative to vehicle in either context 
(treatment main and treatment × context interaction effects, N.S.). Similarly, exposure to the 
cocaine-paired context slightly increased responding on the inactive lever relative to 
responding in the extinction context (context main effect, F(1,11) = 7.275, p = 0.021, Fig. 
2d). Furthermore, intra-SStr administrations of JNJ16259685 failed to alter inactive lever 
responding relative to vehicle in either context (treatment main and treatment × context 
interaction effects, N.S.).
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Effects of intra-DH JNJ16259685 treatment on locomotor activity and food-reinforced 
instrumental behavior
Intra-DH administration of JNJ16259685 failed to alter locomotor activity in a novel context 
relative to vehicle (Fig. 3a). The number of photobeam breaks decreased across the three 20-
min intervals of the motor activity test session (time main effect, F(2,48) = 54.601, p = 
0.0001; interval 1 > 2–3, Tukey test, p < 0.05). Furthermore, the 30 or 120 pg doses of 
JNJ16259685 administered into the DH failed to alter the number of photobeam breaks 
relative to vehicle (treatment main and time × treatment interaction effects, N.S.).
Intra-DH administration of JNJ16259685 failed to alter preprandial (Fig. 3b) or postprandial 
(Fig. 3c) food-reinforced instrumental behavior in context 1 or 2, relative to vehicle. 
Vehicle-pretreated rats exhibited more active lever presses for food reinforcement in the 
preprandial condition (Mean ± SEM = 359.40 ± 47.09) than in the postprandial condition 
(Mean ± SEM = 64.75 ± 7.77). However, intra-DH administrations of the 30 or 120 pg 
doses of JNJ16259685 failed to alter preprandial or postprandial food-reinforced active 
(F(2,21–30) = 0.091–1.485, N.S.) or inactive lever responding (F(2,21–30) = 0.060–1.056, 
N.S.), relative to vehicle.
DISCUSSION
The present study, to our knowledge, demonstrates for the first time that the expression of 
drug context-induced instrumental cocaine-seeking behavior relies on glutamatergic 
neurotransmission in the DH via the stimulation of mGluR1s. Blockade of the mGluR1s in 
the DH by JNJ16259685, a highly selective mGluR1 receptor antagonist (Lavreysen et al. 
2004b; Fukunaga et al. 2007), dose-dependently attenuated the expression of drug context-
induced cocaine seeking in rats. Impairment in cocaine seeking was brain region specific, 
since administration of JNJ16259685 into the overlying SStr failed to alter this behavior. 
Also, impairment in cocaine seeking was not due to nonspecific effects on general activity 
or instrumental motor performance, since administration of behaviorally effective doses of 
JNJ16259685 into the DH failed to inhibit locomotor activity and preprandial or 
postprandial food-reinforced instrumental behavior. Furthermore, impairment in cocaine-
seeking behavior was lever and context specific, since JNJ16259685 treatment failed to alter 
inactive lever responding in the previously cocaine-paired context or active lever responding 
in the extinction context. Taken together, these findings suggest that stimulation of mGluR1 
receptors in the DH is necessary for drug context-induced cocaine-seeking behavior. It 
should be considered, however, that the hippocampus as well as mGluR1s have been 
implicated in memory processes (Maciejak et al. 2003; Simonyi et al. 2007; Sukhotina et al. 
2008). For instance, systemic administration of the mGluR1 antagonist EMQMCM inhibits 
the expression of hippocampus-dependent contextual fear conditioning (Gravius et al. 2006). 
mGluR1s may therefore play a role in the recall or utilization of context-response-cocaine 
associations that are thought to contribute to drug-seeking behavior in our model (Fuchs et 
al. in press). Thus it is unclear whether mGluR1 stimulation in the DH mediates memory 
and/or motivational processes that contribute to this behavior.
The possible contribution of mGluR1 to drug-induced behavior has not been studied 
extensively. Study of mGluR1 function has been restricted until the recent availability of 
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selective mGluR1 antagonists, including JNJ16259685, BAY36-7620, YM-230888, and 
EMQMCM (De Vry et al. 2001; Lavreysen et al. 2004b; Sevostianova and Danysz 2006; 
Kohara et al. 2007). In the present study, we utilized JNJ16259685, a highly potent non-
competitive mGluR1 antagonist (in vitro IC50 < 19 nM) (Lavreysen et al. 2004b; Fukunaga 
et al. 2007). JNJ16259685 displays a greater than 1,000-fold selectivity for mGluR1 over 
mGluR5 in Ca2+ mobilization assays (Lavreysen et al. 2004b), it does not act as a positive 
allosteric modulator of other mGluRs subtypes (i.e., mGluR2, mGluR3, mGluR4, and 
mGluR6; Lavreysen et al. 2004b), and it has no affinity for NMDA or AMPA ionotropic 
glutamate receptors (in vitro IC50 > 10 µM) (Lavreysen et al. 2004b). Hence, the 
JNJ16259685-induced impairment in drug context-induced cocaine-seeking behavior in the 
present study was likely due to the selective blockade of mGluR1 in the DH. Nevertheless, 
given that the pharmacology of JNJ16259685 has not been extensively studied in vivo, it 
will be important to verify the receptor selectivity of this effect using selective mGluR1 
agonists, once these become available.
Although mGluR1 antagonism in the DH selectively impairs drug context-induced cocaine-
seeking behavior, mGluR1s have also been implicated in motor behavior and food-
motivated goal-directed behavior. While, in the present study, administration of 
JNJ16259685 into the DH failed to alter the locomotor activity, systemic infusions of 
JNJ16259685 impair locomotor activity (Steckler et al. 2005; Besheer et al. 2008). These 
systemic effects of JNJ16259685 likely result from the inhibition of mGluR1s in brain 
regions other than the DH, such as cerebellum (Ichise et al. 2000; Nakao et al. 2007) which 
exhibits high mGluR1 density (Masu et al. 1991; Shigemoto et al. 1992; Lavreysen et al. 
2004a) or the NAC (Besheer et al. 2009). The present findings suggested that mGluR1s in 
the DH do not play a critical role in the reinforcing effects of food; however, it remains to be 
investigated whether they contribute to context-induced motivation for natural reward. 
Systemic mGluR1 antagonism using EMQMCM attenuates explicit CS-induced 
reinstatement of food-seeking behavior (Dravolina et al. 2007). Thus, it is possible that 
intra-DH administration of JNJ16259685 would have a similar effect on context-induced 
reinstatement of food-seeking behavior. However, context-induced natural reward-seeking 
behavior is difficult to study in isolation due to the presence of response-contingent visual 
and olfactory stimuli associated with natural rewards. These sensory stimuli are established 
as CSs during training. They can suppress contextual conditioning due to overshadowing: a 
well documented interference with the conditioning of a stimulus (i.e., the context) because 
of the simultaneous presence of another stimulus (i.e., food-related CS) that is easier to 
condition (Domjan 1998). Additionally, they may alter the neural systems recruited to 
control food-seeking behavior. Consistent with a possible overshadowing effect, our attempt 
to examine the effects of intra-DH JNJ16259685 (30 pg/0.5 µl per hemisphere) on context-
induced reinstatement of food-seeking behavior was unsuccessful (data not shown). In this 
experiment, all training and testing procedures were identical to those in the cocaine 
reinstatement experiments reported here except that a natural reinforcer (45-mg food pellets) 
was used. Under these experimental conditions, exposure to the previously food-paired 
context failed to reinstate extinguished food-seeking behavior following vehicle (8.25 ± 2.76 
active lever presses) or JNJ16259685 administration into the DH (12.16 ± 2.76 active lever 
presses), relative to responding in the extinction context (9.68 ± 2.22 active lever presses).
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The effect of JNJ16259685 on context-induced reinstatement of cocaine-seeking behavior 
appears to be mediated by inhibition of mGluR1 receptor signaling, but the exact 
hippocampal receptor subpopulations and possible receptor interactions that mediate this 
effect have yet to be identified. In vitro studies have shown that JNJ16259685 inhibits 
glutamate-induced inositol phosphate production, Ca2+ mobilization, and the generation of 
mGluR1-mediated EPSPs (Lavreysen et al. 2004b, Fukunaga et al. 2007). mGluR1s are 
preferentially expressed postsynaptically within the DH (Ferraguti et al. 2004; Ferraguti and 
Shigemoto 2006). While the expression of mGluR1s is largely uniform throughout the 
hippocampus proper, critical mGluR1 populations may be located postsynaptically on CA1 
pyramidal neurons. Stimulation of these mGluR1s has direct excitatory effects on CA1 
pyramidal neurons, resulting in depolarization and increased cell firing (Desai and Conn 
1991; Mannaioni et al. 2001). However, mGluR1s are also located on GABAergic inhibitory 
interneurons within the hippocampus (van Hooft et al. 2000; Topolnik et al. 2005), and the 
stimulation of these receptors inhibits the CA3-CA1 synapse (Mannaioni et al. 2001). 
Therefore, in the present study, we are not able to ascribe the effects of JNJ16259685 on 
cocaine-seeking behaivor to the blockade of a specific mGluR1 subpopulation within the 
DH. Studies have revealed functional interactions between mGluR1 and NMDA receptors. 
Specifically, in vitro stimulation of mGluR1 potentiates NMDA receptor-mediated currents 
and accelerates NMDA receptor trafficking (Krieger et al. 2000; Lan et al. 2001; Skeberdis 
et al. 2001). Hence, although JNJ16259685 has no affinity for the NMDA receptor 
(Lavreysen et al. 2004b), functional interactions between mGluR1s and NMDA receptors 
might contribute to the effect of JNJ16259685 on cocaine-seeking behavior in the present 
study. Future studies examining the effects of a sub-threshold dose of JNJ16259685 co-
administered with an NMDA receptor antagonist (e.g. MK-801) may provide insight into 
this question.
In summary, the main contribution of the present study is to demonstrate that stimulation of 
mGluR1s in the DH is critical for the expression of drug context-induced reinstatement of 
cocaine-seeking behavior. Thus, the mGluR1 is a potential target of pharmacotherapeutic 
prevention of drug relapse. As these findings imply, glutamatergic neurotransmission within 
the DH is critical for drug context-induced reinstatement of cocaine-seeking behavior, but 
the source of glutamate input has yet to be identified. Anatomical studies indicate that the 
hippocampus proper – including the DH and ventral hippocampus (VH) – receives sensory 
input via glutamatergic fibers from sensory association cortical areas, and projects 
reciprocally to the dorsomedial prefrontal cortex (dmPFC), which has also been identified as 
a mediator of context-induced reinstatement of cocaine-seeking behavior (Jay et al. 1992; 
Moser and Moser 1998; Fuchs et al. 2005; 2007). Using the functional disconnection 
technique, we have demonstrated that serial information processing by the basolateral 
amygdala (BLA) and DH is necessary for drug context-induced cocaine-seeking behavior 
(Fuchs et al. 2007). While cholinergic and noradrenergic neurotransmission within the BLA 
have been indicated in modulating hippocampal neuron activity (Dringenberg et al. 1996; 
Roozendaal et al. 1999), it remains to be determined whether glutamatergic input from the 
BLA to the DH contributes to drug context-induced cocaine-seeking behavior. Given that 
direct anatomical connections between the BLA and DH are sparse, interactions between 
these brain regions may occur via an intermediary, such as the lateral entorhinal cortex 
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(Fuchs et al. 2007). Conversely, dense reciprocal glutamatergic connections exist between 
the BLA and the VH (van Groen and Wyss 1990), which also plays a role in context-
induced cocaine-seeking behavior (Lasseter et al. 2009). However, it has yet to be 
determined whether the BLA and VH are functionally interdependent with respect to this 
behavior. It has been theorized that, upon drug-context exposure, the information from the 
DH, VH, and BLA is integrated by the dmPFC, which initiates the expression of drug 
context-induced cocaine-seeking behavior via inputs to the nucleus accumbens (NAC; Fuchs 
et al. 2008; Lasseter et al. in press). Alternatively, information from the DH, VH, BLA, and 
dmPFC may converge at the level of the NAC (van Groen and Wyss 1990; Amaral and 
Witter 1995; O’Donnell and Grace 1995; Groenewegen et al. 1999; Goto and O’Donnell 
2002; Peleg-Raibstein and Feldon 2006; Fuchs et al. 2008; Lasseter et al. 2009), likely 
permitting greater hippocampal influence over cocaine-seeking behavior. Future studies will 
need to investigate the neuropharmacological mechanisms underlying the putative 
interactions between these subcircuits in order to better understand the role of the 
hippocampus in cocaine addiction and to advance drug relapse prevention.
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Schematic and photographic representation of injection cannula placements within the 
dorsal hippocampus (DH) and trunk region of the somatosensory cortex (SStr). Arrows 
identify the most ventral point of the infusion cannula tracts on each photomicrograph of 
representative cresyl violet-stained brain sections. Filled circles, open triangles, and open 
circles represent the most ventral point of the cannula tracts for rats in the DH-cannulated 
cocaine-trained, DH-cannulated food-trained, and SStr-cannulated cocaine-trained groups, 
Xie et al. Page 16













respectively, on schematics from the rat brain atlas of Paxinos and Watson (1997). Numbers 
indicate the distance from bregma in millimeters.
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Non-reinforced active and inactive lever responses (mean/1 h ± SEM) during testing in the 
extinction (EXT) and previously cocaine-paired contexts (COC). JNJ16259685 or vehicle 
was infused bilaterally into the DH (A, B: N = 10–14/group) or the SStr (C, D: N = 12) 
before testing. The Asterisks represent a significant difference relative to responding in the 
extinction context (Panel A: ANOVA context simple main effect, Tukey test, p < 0.05; 
Panels B, C, D: ANOVA context main effect, p < 0.05). The Dagger represents a significant 
difference relative to the vehicle treatment (ANOVA treatment simple main effect, Tukey 
test, p < 0.05).
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Locomotor activity (A; mean photobeam breaks/1 h ± SEM) in a novel context as well as 
preprandial food-reinforced instrumental behavior (B; mean lever presses/1 h ± SEM) and 
postprandial food-reinforced instrumental behavior (C; mean lever presses/1 h ± SEM) in 
contexts 1 or 2. JNJ16259685 or vehicle was administered bilaterally into the DH (Panel A: 
N = 10–14/group; Panel B: N = 10; Panel C: N = 8) before testing. Rats in the postprandial 
condition received 100 45-mg food pellets 1 h before each behavioral session. The Plus sign 
represents a significant difference relative to all other time points (ANOVA time simple 
main effect, Tukey test, p < 0.05).
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